Reg No. :AS20SDA127074 Name : Kaustav Jyoti Kachari Institute: Dibrugarh University Email : [email protected] Phn No. : 7086545017 Covid 19 and vaccination The unexpected outbreak of Covid-19 disease has led the world to an unexpected public health crisis. Since its emergence in Asia in late 2019, the virus has spread all Over the world. The pandemic is moving like a wave and countries are trying to slow The spread of the virus by testing and treating patients, carrying out contact tracing, Limiting travel and cancelling large mass gathering etc. Educational institute are also Closed. Covid-19 has created devastating economic crises. Everyday people are losing jobs and income, with no way of knowing when normality will return. The enormous scale of the crisis and the impact it is having are naturally causing a lot of fear, uncertainty and anxiety across the globe. Add social isolation, disrupted work and family routines, cabin fever and economic instability, and it is understandable that our mental health is suffering. In a recent survey by the Kaiser Family Foundation, 45% of adults feel that worry and stress related to coronavirus has had a negative impact on their mental health. With lot of research, the scientists and the researchers are able develop the Covid 19 Vaccine. A COVID-19 vaccine is a vaccine intended to provide acquired Immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On 10 January 2020, the SARS-CoV-2 genetic sequence data was shared through GISAID, And by 19 March, the global pharmaceutical industry announced a major commitment To address COVID-19 In Phase III trials, several COVID-19 vaccines have demonstrated efficacy as high as 95% in preventing symptomatic COVID-19 infections. As of April 2021, 16 vaccines are authorized by at least one national regulatory authority for public use: three RNA Vaccines (Pfizer–BioNTech and Moderna), seven conventional inactivated Vaccines (BBIBP-CorV, CoronaVac, Covaxin, WIBP-CorV, CoviVac, MinhaiKangtai and QazVac), five viral vector vaccines (Sputnik Light, Sputnik V, Oxford–AstraZeneca, Convidecia, and Johnson & Johnson), and two protein subunit Vaccines (EpiVacCorona and RBD-Dimer). As of 27 May 2021, 1.81 billion doses of COVID-19 vaccine have been administered worldwide based on official reports from national health agencies. AstraZeneca Anticipates producing 3 billion doses in 2021, Pfizer– BioNTech 1.3 billion doses, and Sputnik V, Sinopharm, Sinovac, and Johnson & Johnson 1 billion doses each. Moderna targets producing 600 million doses and Convidecia 500 million doses in 2021. By December 2020, more than 10 billion vaccine doses had been preordered by countries, with about half of the doses purchased by high-income countries. From the December 2020, people all over the world have started to get vaccinated. Now people may ask how does covid 19 vaccine? So here is the answer, Vaccines prompt the immune system to make antibodies to defend against specific diseases. In other words — they make the immune system behave as if the body already had this illness. After vaccination, the person develops immunity to the disease. Their body can fight off the infection if exposure to the pathogen, such as the novel coronavirus occurs. An effective vaccine stimulates the immune system without kicking it into overdrive. It is essential to receive the vaccine from a licensed healthcare professional and follow every instruction, including getting a second dose. In the short term, a Person who has had a COVID-19 vaccine may experience flu-like symptoms and other side effects, including: pain at the injection site, swelling at the injection site, fatigue headache and muscle pain. Anyone with a history of allergiesTrusted Source to Vaccines or other injectable medications should tell the healthcare worker before they administer the vaccine. Like all over the world, India also has started to distribute vaccines from the ending of 2020. There are three vaccines distributed in India which are Covaxin and Covishield Manufactured by India, and the third one is Sputnik V by Russia. The Serum Institute Of India (SII) makes Covishield (under license from AstraZeneca), whilst the second Largest producer, Bharat Biotech, makes the locally-developed Covaxin. Indian Government has taken many steps for distribution of covid 19 vaccine which are available in local hospitals and health care centers all over the India. In early April, daily vaccinations peaked at 3.6 million but that figure has since fallen back to around 1.6 Million per day. This dip is due to the shortage and wastage of vaccines in India. The Centre has so far provided nearly 16 crore vaccine doses to States of which the total Consumption including wastage is 14.8 crore doses. Maharashtra led the table of Vaccines administered with 1.5 crore doses followed by Rajasthan (1.3 crore), Uttar Pradesh (1.25 crore) and Gujarat (1.23 crore). These were also the States that had so Far received the maximum number of vaccines, again in that order. Among large States, Tamil Nadu reported a high percentage of vaccine wastage, nearly 8.83%. Only Lakshadweep had a higher 9.76%. Assam, Manipur and Haryana ranked after Tamil Nadu in percentage wastage of vaccines, at 7.7%, 7.4%and 5.72%. The Andaman and Nicobar Islands, Arunachal Pradesh, Goa, Himachal Pradesh, Kerala, Mizoram, Odisha Were the States that had reported no wastage. These wastage may occur due to many Factors poor planning of the center, vaccines arriving after expiry etc. The NCC is playing a great role in this pandemic time. The cadets are coming forward to contribute to the society by helping in vaccination centers, distribute food and other necessary materials to the people. In the rural parts there were also many myths about Covid 19 vaccine so as a NCC cadet it is our duty to tell people about the vaccine and it’s effectiveness and also help them getting these vaccines. In this pandemic we are all in together and we should believe that this too shall pass. So take the vaccines at your turn, maintain the covid 19 guidelines and we will get over this soon. .